@article {10567,
	title = {Intranasal Dexmedetomidine Sedation as Adjuvant Therapy in Acute Asthma Exacerbation With Marked Anxiety and Agitation.},
	journal = {Ann Emerg Med},
	volume = {69},
	year = {2017},
	month = {2017 01},
	pages = {125-127},
	abstract = {<p>We describe 2 patients with acute asthma exacerbation who were admitted to the emergency department (ED) with severe~agitation and restlessness as a prominent finding, for which bedside asthma treatment sedation with intranasal dexmedetomidine was performed. In both cases, dexmedetomidine allowed the patients to rest and improved tolerance to treatment. Dexmedetomidine is a unique sedative with an excellent safety profile and minimal effect on respiratory function. These properties render it particularly promising for the management of severe agitation in children admitted to the ED with acute asthma exacerbation.</p>},
	keywords = {Acute Disease, Administration, Intranasal, Anxiety, Asthma, Child, Preschool, Dexmedetomidine, Emergency Service, Hospital, Female, Humans, Hypnotics and Sedatives, Infant, Psychomotor Agitation},
	issn = {1097-6760},
	doi = {10.1016/j.annemergmed.2016.08.005},
	author = {Cozzi, Giorgio and Lega, Sara and Giorgi, Rita and Barbi, Egidio}
}
